Merit Medical Systems Inc (MMSI) stock
Close on Nov 17, 2026Market cap $5.06BP/E 31.8Yield –
Earnings
Merit Medical Systems's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.
Quarterly results
Revenue and earnings per share from each of Merit Medical Systems's earnings releases, newest first
| Quarter | Reported | Revenue | YoY | EPS | Adj. EPS | Source |
|---|---|---|---|---|---|---|
| Q4 FY2026ended Dec 31, 2026 | Feb 23, 2027Expected | – | – | – | – | – |
| Q3 FY2026ended Sep 30, 2026 | Oct 29, 2026after the close | $416.20M | +8.3% | $0.70 | $1.12 | Release |
| Q2 FY2026ended Jun 30, 2026 | Jul 30, 2026during market hours | $418.80M | +9.5% | $0.65 | $1.19 | Release |
| Q1 FY2026ended Mar 31, 2026 | Apr 30, 2026during market hours | $381.90M | +7.5% | $0.68 | $0.94 | Release |
| Q4 FY2025ended Dec 31, 2025 | Feb 24, 2026during market hours | $393.90M | +10.9% | $0.63 | $1.04 | Release |
| Q3 FY2025ended Sep 30, 2025 | Oct 30, 2025during market hours | $384.20M | +13.1% | $0.46 | $0.92 | Release |
| Q2 FY2025ended Jun 30, 2025 | Jul 30, 2025during market hours | $382.50M | +13.2% | $0.54 | $1.01 | Release |
| Q1 FY2025ended Mar 31, 2025 | Apr 24, 2025during market hours | $355.40M | +9.9% | $0.49 | $0.86 | Release |
| Q4 FY2024ended Dec 31, 2024 | Feb 25, 2025during market hours | $355.20M | +9.5% | $0.46 | $0.93 | Release |
| Q3 FY2024ended Sep 30, 2024 | Oct 30, 2024during market hours | $339.80M | +7.8% | $0.48 | $0.86 | Release |
| Q2 FY2024ended Jun 30, 2024 | Aug 1, 2024during market hours | $338.00M | +5.6% | $0.61 | $0.92 | Release |
| Q1 FY2024ended Mar 31, 2024 | Apr 30, 2024during market hours | $323.50M | +8.7% | $0.48 | $0.77 | Release |
| Q4 FY2023ended Dec 31, 2023 | Feb 28, 2024during market hours | $324.50M | +10.6% | $0.47 | $0.81 | Release |
| Q3 FY2023ended Sep 30, 2023 | Oct 26, 2023during market hours | $315.20M | +9.7% | $0.44 | $0.75 | Release |
| Q2 FY2023ended Jun 30, 2023 | Jul 25, 2023during market hours | $320.10M | +8.5% | $0.35 | $0.81 | Release |
| Q1 FY2023ended Mar 31, 2023 | Apr 26, 2023during market hours | $297.60M | +8.1% | $0.36 | $0.64 | Release |
| Q4 FY2022ended Dec 31, 2022 | Feb 22, 2023during market hours | $293.40M | +5.4% | $0.58 | $0.79 | Release |
| Q3 FY2022ended Sep 30, 2022 | Oct 26, 2022during market hours | $287.20M | +7.6% | $0.27 | $0.64 | Release |
| Q2 FY2022ended Jun 30, 2022 | Jul 27, 2022during market hours | $295.00M | – | $0.27 | $0.73 | Release |
| Q1 FY2022ended Mar 31, 2022 | Apr 27, 2022during market hours | $275.40M | – | $0.18 | $0.53 | Release |
| Q4 FY2021ended Dec 31, 2021 | Feb 24, 2022during market hours | $278.50M | – | $0.36 | $0.71 | Release |
| Q3 FY2021ended Sep 30, 2021 | Oct 28, 2021during market hours | $267.00M | – | $0.21 | $0.52 | Release |
| Q2 FY2021ended Jun 30, 2021 | Jul 29, 2021during market hours | – | – | – | – | Filing |
| Q1 FY2021ended Mar 31, 2021 | Apr 29, 2021during market hours | – | – | – | – | Filing |
| Q4 FY2020ended Dec 31, 2020 | Feb 24, 2021during market hours | – | – | – | – | Filing |
| Q3 FY2020ended Sep 30, 2020 | Oct 28, 2020during market hours | – | – | – | – | Filing |
Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.
Current guidance
Merit Medical Systems's latest outlook for periods it has not reported yet, compared with what it said before
| Metric | Period | Guidance | Before | Change | Given |
|---|---|---|---|---|---|
| Total revenueGAAP | FY2026 | $1.61B – $1.63B | – | New | Feb 24, 2026 |
| Total Revenue | FY2026 | $1.61B – $1.63B | – | New | Apr 30, 2026 |
| Non-GAAP Earnings Per Sharenon-GAAP | FY2026 | $4.01 – $4.15 | – | New | Apr 30, 2026 |
| Non-GAAP EPSnon-GAAP | FY2026 | $4.01 – $4.15 | – | New | Feb 24, 2026 |
Guidance history
Every forecast Merit Medical Systems put in an earnings release, newest first
| Given | Metric | Period | Guidance | Change |
|---|---|---|---|---|
| Apr 30, 2026 | Non-GAAP Earnings Per Share | FY2026 | $4.01 – $4.15 | New |
| Apr 30, 2026 | Total Revenue | FY2026 | $1.61B – $1.63B | New |
| Feb 24, 2026 | Non-GAAP EPS | FY2026 | $4.01 – $4.15 | New |
| Feb 24, 2026 | Total revenue | FY2026 | $1.61B – $1.63B | New |
| Feb 25, 2025 | Non-GAAP EPS | FY2025 | $3.58 – $3.70 | New |
| Feb 25, 2025 | Revenue | FY2025 | $1.47B – $1.49B | New |
| Oct 26, 2022 | cumulative free cash flow | FY2023 | $300.00M | New |
| Oct 26, 2022 | non-GAAP operating margins | FY2023 | 18% | New |
| Oct 26, 2022 | constant currency, organic revenue | FY2023 | +5% | New |
| Jul 27, 2022 | Non-GAAP net income per diluted share | FY2022 | $2.42 – $2.52 | Narrowed |
| Jul 27, 2022 | GAAP net income per diluted share | FY2022 | $1.08 – $1.18 | Lowered |
| Jul 27, 2022 | Net revenue | FY2022 | $1.12B – $1.14B | Narrowed |
| Apr 27, 2022 | diluted share | FY2022 | $2.41 – $2.56 | Reaffirmed |
| Apr 27, 2022 | diluted share | FY2022 | $1.30 – $1.45 | Reaffirmed |
| Apr 27, 2022 | Net revenue | FY2022 | $1.12B – $1.14B | New |
| Feb 24, 2022 | per diluted share | FY2022 | $2.41 – $2.56 | New |
| Feb 24, 2022 | per diluted share | FY2022 | $1.30 – $1.45 | New |
| Feb 24, 2022 | Net revenue | FY2022 | $1.12B – $1.14B | New |
Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.
Press releases
Releases Merit Medical Systems filed with the SEC as exhibits to Form 8-K or 6-K
- Results
- Results
- Results
- Update
- Results
- Results
- Update
- Update
- Update
- Results
- Results
- Update
- MERIT MEDICAL REPORTS FOURTH QUARTER AND FULL YEAR 2025 RESULTS AND ISSUES FISCAL YEAR 2026 GUIDANCEResults
- Results
- Results
See a number that looks wrong?